References and Notes
1
Kobayashi J.
Tsuda M.
Nat. Prod. Rep.
2004,
21:
77
2
Tsuda M.
Izui N.
Shimbo K.
Sato M.
Fukushi E.
Kawabata J.
Kobayashi J.
J. Org. Chem.
2003,
68:
9109
3
Tsuda M.
Izui N.
Shimbo K.
Sato M.
Fukushi E.
Kawabata J.
Kkatsumata K.
Horiguchi T.
Kobayashi J.
J. Org. Chem.
2003,
68:
5339
4 Total synthesis of amphidinolide X, see: Lepage O.
Kattnig E.
Fürstner A.
J. Am. Chem. Soc.
2004,
126:
15970
5a
Corey EJ.
Guzman-Perez A.
Noe MC.
J. Am. Chem. Soc.
1995,
117:
10805
5b For the 2-propyl homologue of 3, see: Hayes PY.
Kitching W.
J. Am. Chem. Soc.
2002,
124:
9718
6
Narayan RS.
Sivakumar M.
Bouhle E.
Borhan B.
Org. Lett.
2001,
3:
2489
7
Johnson RA.
Sharpless KB. In
Catalytic Asymmetric Synthesis
2nd ed.:
Ojima I.
Wiley-VCH;
New York:
2000.
p.231
For a recent example of asymmetric homoallylic epoxidation, see:
8a
Makita N.
Hoshino Y.
Yamamoto H.
Angew. Chem. Int. Ed.
2003,
42:
941
8b See also: Rossiter BE.
Sharpless KB.
J. Org. Chem.
1984,
49:
3707
9
Katsuki T.
Sharpless KB.
J. Am. Chem. Soc.
1980,
102:
5974
10
Coxon JM.
Hartshorn MP.
Swallow WH.
Aust. J. Chem.
1973,
26:
2521
For selected examples of other modes of epoxide ring-opening cyclization, see:
11a
Nakata T.
Kishi Y.
Tetrahedron Lett.
1978,
2745
11b
Nakata N.
Schmid G.
Vranesic B.
Okigawa M.
Smith-Palmer T.
Kishi Y.
J. Am. Chem. Soc.
1978,
100:
2933
11c
Nicolaou KC.
Brasad CVC.
Somers PK.
Hwang C.-K.
J. Am. Chem. Soc.
1989,
111:
5330
11d
Nicolaou KC.
Prasad CVC.
Somers PK.
Hwang C.-K.
J. Am. Chem. Soc.
1989,
111:
5335
11e
Mukai C.
Ikeda Y.
Sugimoto Y.
Hanaoka M.
Tetrahedron Lett.
1994,
35:
2179
11f
Fujiwara K.
Tokiwano T.
Murai A.
Tetrahedron Lett.
1995,
36:
8063
11g
Fujiwara K.
Mishima H.
Amano A.
Tokiwano T.
Murai M.
Tetrahedron Lett.
1998,
39:
393
11h
Evans PA.
Murthy VS.
Tetrahedron Lett.
1999,
40:
1253
12
Ley SV.
Norman J.
Griffith WP.
Marsden SP.
Synthesis
1994,
639
13 Spectroscopic data of 23: [α]D
20 -23.3 (c 0.60, CHCl3). IR (film): 2959, 2932, 1613, 1514, 1249, 1111, 1090, 1072, 1037 cm-1. 1H NMR (400 MHz, CDCl3): δ = 7.30-7.23 and 6.89-6.86 (A2B2, 4 H), 5.86 (ddd, J = 17.6, 10.8, 6.8 Hz, 1 H), 5.35 (dt, J = 17.2, 1.6 Hz, 1 H), 5.15 (dt, J = 10.4, 1.6 Hz, 1 H), 4.47 and 4.43 (ABq, J = 11.6 Hz, 2 H), 4.38 (dd, J = 6.4, 6.4 Hz, 1 H), 3.86-3.80 (m, 1 H), 3.80 (s, 3 H), 2.03 (dd, J = 12.8, 8.0 Hz, 1 H), 1.81 (dd, J = 13.2, 5.2 Hz, 1 H), 1.52-1.46 (m, 2 H), 1.40-1.32 (m, 2 H), 1.33 (s, 3 H), 0.92 (t, J = 7.2 Hz, 3 H). 13C NMR (100 MHz, CDCl3): δ = 159.1, 137.8, 130.2, 129.1 (2×), 116.2, 113.7 (2×), 84.0, 83.5, 83.0, 71.4, 55.2, 45.0, 42.3, 26.3, 17.8, 14.6. MS (+ESI):
m/z (%) = 603 (80) [2 M + Na+], 313 (100) [M + Na+],
290 (10) [M+]. HRMS (+ESI): m/z calcd for C18H26O3Na+: 313.1780 [M + Na+]; found: 313.1776.
14 Spectroscopic data of 24: [α]D
20 -52.2 (c 0.8, CHCl3, >96% ee); lit. (ref. 4) [α]D
20 -37.1 (c 1.0, CHCl3, 83% ee). 1H NMR (400 MHz, CDCl3): δ = 7.24 (d, J = 8.5 Hz, 2 H), 6.88 (d, J = 8.5 Hz, 2 H), 4.48 and 4.39 (ABq, J = 11.5 Hz, 2 H), 4.06 (ddd, J = 8.5, 5.0, 5.0 Hz, 1 H), 3.81 (s, 3 H), 3.80-3.74 (m, 3 H), 2.96 (br s, 1 H), 2.05 (dd, J = 12.5, 8.0 Hz, 1 H), 1.89-1.70 (m, 2 H), 1.78 (dd, J = 13.0, 5.0 Hz, 1 H), 1.50-1.45 (m, 2 H), 1.38-1.28 (m, 2 H), 1.31 (s, 3 H), 0.92 (t, J = 7.5 Hz, 3 H). 13C NMR (100 MHz, CDCl3): δ = 159.2, 129.8, 129.2 (2×), 113.9 (2×), 83.4, 83.2, 82.1, 71.5, 61.3, 55.2, 45.0, 42.3, 35.9, 26.3, 17.7, 14.5. MS (+ESI): m/z (%) = 639 (100) [2 M + Na+], 617 (53) [2 M + H+], 331 (100) [M + Na+], 309 (64) [M + H+]. HRMS (+ESI): m/z calcd for C18H28O4Na+: 331.1885 [M + Na+]; found: 331.1876.